CSV-ViT: A Vision Transformer with the Variable-sized Cortical Supervertices for Detection of Alzheimer's Disease Pathologies

Researchers developed CSV-ViT, a Vision Transformer model that uses variable-sized cortical surface patches to detect Alzheimer's disease pathologies from structural MRI scans. The method outperforms existing surface-based models and could enable earlier AD diagnosis through non-invasive imaging, potentially reducing reliance on costly PET scans and invasive cerebrospinal fluid testing.

CSV-ViT addresses a critical limitation in neuroimaging AI: the difficulty of applying deep learning to non-Euclidean brain surface data. Previous surface-based models struggled with duplicate vertices at patch boundaries and often included non-cortical regions like the medial wall, reducing diagnostic accuracy. The breakthrough involves cortical surface tokenization that partitions the brain's cortical surface into variable-sized patches—called cortical supervertices—while preserving regions of interest and eliminating duplicate vertex problems.

This advancement builds on the broader trend of specializing deep learning architectures for domain-specific data geometries. Rather than forcing brain surface data into Euclidean frameworks, CSV-ViT respects the spherical topology of cortical surfaces while maintaining computational efficiency through a mask-aware Vision Transformer design. The framework was validated against a challenging clinical task: classifying AD diagnosis, amyloid positivity, and tau positivity from T1-weighted MRI alone.

The clinical implications are substantial. Alzheimer's disease typically requires expensive PET imaging or invasive cerebrospinal fluid analysis for confirmation. If CSV-ViT can accurately predict these biomarkers from routine MRI scans, it could enable earlier detection and more accessible screening globally. This matters for healthcare providers aiming to identify at-risk patients before symptomatic decline and for patients who face barriers to specialized neuroimaging.

For the broader AI medical imaging sector, this demonstrates how tailored architectures for specialized data types can outperform generic approaches. The research suggests future development in domain-aware neural networks for neuroimaging, potentially extending to other neurodegenerative diseases.

• →CSV-ViT uses variable-sized cortical patches to overcome boundary artifacts plaguing previous surface-based brain models
• →The framework successfully classifies AD diagnosis, amyloid positivity, and tau positivity from MRI alone, outperforming existing methods
• →MRI-based AD biomarker prediction could reduce reliance on invasive CSF testing and expensive PET imaging for screening
• →The approach respects the spherical topology of brain cortical surfaces rather than forcing data into Euclidean frameworks
• →This advancement demonstrates the value of architecture specialization for domain-specific data geometries in medical AI